Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Walton

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
BMJ (Clinical Research Ed.)|June 20, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive designMunyaradzi Dimairo, Philip Pallmann, James Wason, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Neurology|April 5, 2015
Challenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G Weinshenker, Gerard Barron, Jacinta M Behne, et al.
Eclinicalmedicine|February 3, 2026
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trialM Parellada, A San José Cáceres, R Delorme, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
BMJ (Clinical Research Ed.)|June 20, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive designMunyaradzi Dimairo, Philip Pallmann, James Wason, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Neurology|April 5, 2015
Challenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G Weinshenker, Gerard Barron, Jacinta M Behne, et al.
Eclinicalmedicine|February 3, 2026
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trialM Parellada, A San José Cáceres, R Delorme, et al.
Pageof 17